Skip to main content
. 2023 Oct 26;34:100737. doi: 10.1016/j.lanepe.2023.100737

Table 1.

State-of-the-art in the approach to treatment of STIs in Europe.a

Antibiotics with intrinsic proven activity in wild-type strains Widespread antimicrobial resistant strains Current first-line Second line when allergy or treatment failure Third line after treatment failure or resistance Resistance guided therapy Pregnancy Empirical combination
Gonorrhoea Penicillin, cephalosporins, carbapenems, tetracyclines, macrolides, aminoglycosides, and fluoroquinolones Penicillin, fluoroquinolones, tetracyclines, macrolides
  • -

    Ceftriaxone 1 g IM as a single dose in settings where patients are likely to return for test of cure

OR
  • -

    Ceftriaxone 1 g IM as a single dose together with azithromycin 2 g as a single oral dose in non-well controlled settings

  • -

    Spectinomycin 2 g IM as a single dose together with azithromycin 2 g as a single oral dose

  • -

    Ciprofloxacin 500 mg as a single oral dose in susceptible strains

  • -

    Gentamicin 240 mg IM as a single dose together with azithromycin 2 g as a single oral dose

  • -

    Ertapenem 1 g IM once daily for three days

OR
  • -

    Cefixime 400 mg as a single oral dose together with azithromycin 2 g as a single oral dose.

Guided by resistance testing Quinolone susceptibility confirmed by molecular tests:
  • -

    Ciprofloxacin 500 mg as a single oral dose

Ceftriaxone resistance:
  • -

    Ceftriaxone 1 g IM as a single dose together with azithromycin 2 g as a single oral dose

  • -

    Spectinomycin 2 g IM as a single dose together with azithromycin 2 g as a single oral dose

  • -

    Ceftriaxone 1 g IM as a single dose together with azithromycin 2 g as a single oral dose

  • -

    Doxycycline 100 mg oral dose twice daily for 7 days given at the same time as ceftriaxone to cover C. trachomatis infection, if not excluded by molecular tests

Mycoplasma genitalium Tetracyclines, macrolides, fluoroquinolones, and streptogramins Macrolides, fluoroquinolones
  • -

    Azithromycin 500 mg on day one, then 250 mg on days 2–5 (oral)

  • -

    Josamycin 500 mg 3 times daily for 10 days (oral)

  • -

    Moxifloxacin 400 mg od for 7 days (oral)

  • -

    Pristinamycin 1 g four times daily for 10 days (oral), 75% cure

OR
  • -

    Minocycline 100 mg two times daily for 14 days (oral), 70% cure

OR
  • -

    Doxycycline 100 mg two times daily for 14 days (oral), 40% cure

Initial syndromic treatment:
  • -

    Doxycycline 100 mg bid, 7 days (while testing for macrolide resistance)

Upon confirmation of macrolide-susceptibility:
  • -

    Azithromycin 500 mg on day one, then 250 mg od days 2–5 (oral)

Macrolide resistance:
  • -

    Moxifloxacin 400 mg od for 7 days (oral)

  • -

    Azithromycin 500 mg on day one, then 250 mg on days 2–5 (oral)

Macrolide-resistance:
  • -

    Postpone treatment until delivery

OR
  • -

    Pristinamycin can be considered if symptomatic.

Syphilis Penicillin, cephalosporins, macrolides, tetracyclines, oxazolidinones Azithromycin Primary, secondary, and early latent syphilis:
  • -

    BPG 2.4 MUI IM as a single dose

Late latent syphilis:
  • -

    BPG 2.4 MUI IM weekly for 3 weeks

Neurosyphilis:
  • -

    Aqueous crystalline penicillin G 3 to 4 MUI IV every 4 h for 10–14 days.

OR
  • -

    Procaine penicillin G 2.4 million units IM once daily, plus probenecid 500 mg orally 4 times/day, both for 10–14 days

Primary, secondary, and early latent syphilis with penicillin allergy:
  • -

    Doxycycline 100 mg orally twice daily for 14 days

OR
  • -

    Ceftriaxone (1 g IV or IM daily for 10–14 day)

Late latent syphilis or neurosyphilis with penicillin allergy:
  • -

    Penicillin allergy desensitization.

First line is BPG, in case of penicillin allergy:
  • -

    Penicillin allergy testing and desensitization.

a

Treatment Guidelines (Europe): https://iusti.org/treatment-guidelines/-accessed 10 June 2023.

Similar Guidelines are available online: https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf (USA); https://sti.guidelines.org.au/ (Australia); https://www.bashh.org/guidelines (UK). BPG: Benzathine penicillin G.